Prof Alessandro Lagana - Multiple myeloma treatment

This content is part of the Research in Practice in Cancer series of interviews with scientists, focusing on how their research work can have impact on medical practice. Click here to follow Research in Practice in Cancer - for free - on Researcher for more great interviews.


You can read and discover Prof. Alessandro Lagana’s research here.


A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma is published in American Society of Clinical Oncology


Hosted on Acast. See acast.com/privacy for more information.

More from Researcher Radio

  1. 06:59Prof Chi Huey Wong - Development of a more effective COVID-19 vaccinesAug 25, 2022
  2. 09:25Prof Alessandro Lagana - Multiple myeloma treatmentAug 10, 2022
  3. 53:52Nanotechnology - Moving research from the lab bench to the market shelfJul 02, 2020
  4. 01:02:19Academic Research in Africa: a Q&A with academic authorsFeb 27, 2020
  5. 51:31Open Access in Asia-Pacific Countries: a Q&A with academicsJan 30, 2020
  6. 01:05:05Exploring the reading habits of academics: a Q&ANov 07, 2019
  7. 01:07:05How to build relationships with academic authors and market to them successfully: a Q&AOct 03, 2019
  8. 35:37Boundary conditions of workplace coaching outcomes - Dr Rebecca JonesFeb 06, 2019
  9. 27:43The Molecular Genetic Basis of Herbivory between Butterflies and their Host-Plants - Dr Sumitha NalluJan 10, 2019
  10. 29:02Multiplexed protein maps link subcellular organization to cellular states - Dr Gabriele GutDec 12, 2018